Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist Effect on AMH Levels
NCT02086279Completed
- Sponsor
- University of Magna Graecia
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
Open-label trial in Uterine Fibroids (UF), endometriosis and pelvic pain, sponsored by University of Magna Graecia. Primary endpoint: Anti-Mullerian Hormone at 6 months. Started Mar 2014; status: completed.
02
Conditions
Uterine Fibroids (UF)endometriosispelvic pain
Beyond the preview
Go deeper on NCT02086279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086279.